Anthony Mollica
Podiatrist · Bellevue, WANPI 1417307679
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (53.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Pinnacle, Inc at 57.9% of the total. Reporting peaked in 2019 at $4,365 and has fallen 96.9% since, to $136 in 2025. Among podiatrist clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 66 payments — averaging $159.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pinnacle, Inc$6K
- Stryker$3K
- Paragon 28, Inc.$553
- Smith+Nephew$281
- Anika Therapeutics, Inc.$232
- Nevro Corp.$203
- plus $613 from 9 others
What the payments were for
- Speaking & faculty fees$140%
- Travel & lodging$2,52424%
- Food & beverage$2,38923%
- Education$5,58253%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pinnacle, Inc | 15 | $6,089 |
| Stryker | 20 | $2,538 |
| Paragon 28, Inc. | 12 | $553 |
| Smith+Nephew | 2 | $281 |
| Anika Therapeutics, Inc. | 3 | $232 |
| Nevro Corp. | 2 | $203 |
| Arthrex | 2 | $190 |
| Zimmer Biomet | 2 | $167 |
| Integra Lifesciences Corporation | 2 | $142 |
| Misonix Inc | 1 | $38 |
| KCI USA, Inc. | 1 | $19 |
| Metrex Research, LLC | 1 | $16 |
| Boston Scientific | 1 | $15 |
| Organogenesis Inc. | 1 | $14 |
| Tenex Health Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INBONE$1,223
- INFINITY$604
- Renasys$145
- Nextremity General Instrument$144
- Stratum Foot Plating System$144
- SILVERBACK$137
- ALLOGRAFT$137
- ALLOWRAP$137
- Stravix$136
- TACTOSET$128
- Omnia$114
- TAR$100
How this compares
$10,509 in reported general payments places this provider in the 90th percentile of 134 podiatrist providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 66 | $1,006 |
| Ciclopirox | 43 | $743 |
| Cephalexin | 27 | $693 |
| Gabapentin | 58 | $453 |
| Ondansetron Hcl | 53 | $373 |
| Clindamycin Hcl | 13 | $228 |
| Meloxicam | 27 | $171 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Bellevue
- J Mari AdadBellevue$3K
- Molly IchikawaBellevue$2K
- Hubert LeeBellevue$2K
- Byron HutchinsonBurien$903K
- Michael DujelaCentralia$99K
- Huy DangCentralia$63K
- Michael FrazierFederal Way$27K
- Ryan StoneBurien$15K
- Alvin NganSeattle$13K
- Tony KimWenatchee$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.